Derma Sciences (DSCI) Posts Q3 Loss of 24c/Share
Tweet
Share
E-mailGet Alerts DSCI Hot Sheet
Price: $7.00 --0%
Financial Fact:
Total operating expenses: 16.51M
Today's EPS Names:
PGR, FEIM, MMED, More
Financial Fact:
Total operating expenses: 16.51M
Today's EPS Names:
PGR, FEIM, MMED, More
Join SI Premium – FREE
Derma Sciences (NASDAQ: DSCI) reported Q3 EPS of ($0.24), $0.13 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $19.6 million versus the consensus estimate of $19 million.
For earnings history and earnings-related data on Derma Sciences (DSCI) click here.
For earnings history and earnings-related data on Derma Sciences (DSCI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ASML Holdings (ASML) Tops Q2 EPS by 59c; offers guidance
- Arctic Fox Lithium to rebrand as NiobiumX Mining on CSE
- Oppenheimer Downgrades IBM (IBM) to Perform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
